BDNF VAL66MET polymorphism impacts alertness and performance in shift workers
Version 3 2024-01-25, 00:22Version 3 2024-01-25, 00:22
Version 2 2022-10-09, 23:59Version 2 2022-10-09, 23:59
Version 1 2021-01-18, 13:36Version 1 2021-01-18, 13:36
journal contribution
posted on 2024-01-25, 00:22authored byAC Burns, TL Sletten, M Magee, Z Hawi, CL Nicholas, R Saxena, S Ftouni, R Grunstein, D Kennaway, Sally FergusonSally Ferguson
Introduction: Night shift work typically occurs under conditions of
circadian misalignment and sleep restriction, resulting in impaired
performance and alertness. There is inter-individual variability in
the degree of impairment consequent to shift work, though little is
known about the genetic factors that confer resistance or vulnerability.
Brain Derived Neurotrophic Factor (BDNF) is a potent modulator
of sleep-wake homeostasis and contains a common functional polymorphism
in its pro-domain (val66met). The present study examined
whether the val66met polymorphism explained inter-individual variability
in shift work tolerance as measured by the psychomotor vigilance
task (PVT) and electroencephalographic (EEG) correlates of alertness.
Methods: Forty-eight night shift workers completed an in-laboratory,
simulated night shift and were genotyped for the val66met polymorphism
(TaqMan assay; rs6265). Participants completed the auditory
PVT and the Karolinska Drowsiness Test (KDT) during the shift.
Results: Genotyping of val66met identified 27 val/val homozygotes
(19 males; age 32.5±9.5) and 21 met allele carriers (12 males; age
31.3±9.0). Both mean reaction time and attentional lapses increased
as a function of time into the simulated night shift, reflecting a general
worsening of performance (both p<0.001). The val66met polymorphism
moderated this effect such that met allele carriers showed
larger increases in mean reaction time and attentional lapses across the
night shift, relative to the val homozygotes (both p<0.05). EEG power
spectrum analysis revealed a three-way interaction between val66met
genotype, time into shift and EEG frequency (p<0.001). Relative to
baseline, met-carriers show greater elevation in delta (0.5–4.5Hz)
power and a greater reduction in alpha (8.5–12.5Hz) and beta (20-
30Hz) power at the end of shift, compared to val homozygotes (all
p<0.001).
Conclusion: Our results demonstrate a heightened vulnerability to the
effects of shift work among met allele carriers, relative to val homozygotes.
The ability to predict an individual’s vulnerability to shift work
from genetic data may be utilised in the targeting of those who would
benefit most from alertness impairment countermeasures.
Support (If Any): Australian National Health and Medical Research
Council (NHMRC) Project Grant: 545871.
Funding
Category 1 - Australian Competitive Grants (this includes ARC, NHMRC)